The webcast is free, and its replay will remain online for at least 30 days. Email questions are accepted from 9 a.m. ET ...

About $1.7 million, including a 15% contingency, is budgeted for Phase 2 drilling at Harrison Lake; the second tranche is ...

The Notes and the related guarantees have not been, and will not be, registered under the Securities Act of 1933, as amended ...

About $250 million is payable at closing and about $65 million 364 days later; regulatory approvals remain, with closing ...

About $7.28 million in estimated net proceeds are intended for working capital, acquisitions and other corporate purposes; ...

AES lists dividend tax-treatment information and payment history on its website; shareholders of record at the Oct. 30 close ...

At US$3.14 each, 9,554,141 shares went to Urion; talks continue on a potential prepayment facility up to US$120 million, with ...

Both boards approved the proposed deal, which still needs shareholder and regulatory approvals; the parties plan to file an ...

The deals included 8,584,375 shares at $64 each and $575 million in 1.50% notes due 2032; Vaxcyte also plans manufacturing ...

Payment is due Oct. 30; Oct. 19 is both ex-date and record date. The rate uses the fund's $11.38 Oct. 8 closing price; future ...

Skouries recently began operations. The project represents more than US$2 billion in investment and is expected to produce ...

Hirsch became CFO and COO; $2.95 million in net proceeds came from warrant exercises. Tokenized equipment leasing and ...